Blockchain Registration Transaction Record

NRx Pharmaceuticals Seeks FDA Approval for Preservative-Free Ketamine Amid Shortage

NRx Pharmaceuticals files for FDA approval of NRX-100, a preservative-free ketamine, addressing U.S. shortage and enhancing drug safety. Learn more about this breakthrough.

NRx Pharmaceuticals Seeks FDA Approval for Preservative-Free Ketamine Amid Shortage

This news is crucial as it highlights a potential solution to the severe ketamine shortage in the U.S., affecting anesthesia and pain management treatments. NRx Pharmaceuticals' preservative-free formulation could improve patient safety by eliminating toxic preservatives, aligning with health initiatives. The company's efforts may expedite access to essential medications, benefiting healthcare providers and patients alike.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x698972c931accf1cd724784d2134d7a8f01c3d75def3ee7ace916d0b80717de1
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintmint_AjX-d8173907ecbcf4ba5909372eb7db4545